|
|
Volumn 94, Issue 5, 1999, Pages 1412-1413
|
|
Hepatitis C therapy: is it really worth it?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
ANTIVIRUS AGENT;
ADULT;
ARTICLE;
COST BENEFIT ANALYSIS;
ECONOMICS;
HEPATITIS C;
HUMAN;
MIDDLE AGED;
QUALITY ADJUSTED LIFE YEAR;
ADULT;
ANTIVIRAL AGENTS;
COST-BENEFIT ANALYSIS;
HEPATITIS C, CHRONIC;
HUMANS;
INTERFERON-ALPHA;
MIDDLE AGED;
QUALITY-ADJUSTED LIFE YEARS;
|
|
EID: 0033129557
PISSN: 00029270
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1572-0241.1999.01412.x Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
